These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 35891350)

  • 1. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.
    Chang CW; Parsi KM; Somasundaran M; Vanderleeden E; Liu P; Cruz J; Cousineau A; Finberg RW; Kurt-Jones EA
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening.
    Vanhulle E; Stroobants J; Provinciael B; Camps A; Noppen S; Maes P; Vermeire K
    Antiviral Res; 2022 Jul; 203():105342. PubMed ID: 35595082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
    Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
    J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
    Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S
    Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
    Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG
    EBioMedicine; 2022 Oct; 84():104270. PubMed ID: 36130476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
    Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
    J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional modelling of SARS-CoV-2 entry in animal models.
    Brooke GN; Prischi F
    Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells.
    Kapczynski DR; Sweeney R; Spackman E; Pantin-Jackwood M; Suarez DL
    Virology; 2022 Apr; 569():1-12. PubMed ID: 35217403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
    Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML
    Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
    Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
    Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
    Gkogkou E; Barnasas G; Vougas K; Trougakos IP
    Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
    Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
    Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
    Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
    J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
    Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
    Huang C; Jiang Y; Yan J
    J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.